TSW
HLF icon

Thompson Siegel & Walmsley’s Herbalife HLF Stock Holding History

Thompson Siegel & Walmsley’s Portfolio HLF Stock Details HLF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.73M Buy
359,816
+84,124
+31% +$1.16M 0.08% 237
2026
Q1 		$4.06M Sell
275,692
-110,695
-29% -$1.81M 0.07% 249
2025
Q4 		$4.98M Sell
386,387
-314,937
-45% -$3.33M 0.08% 221
2025
Q3 		$5.92M Sell
701,324
-90,497
-11% -$853K 0.1% 201
2025
Q2 		$6.83M Sell
791,821
-19,984
-2% -$148K 0.11% 172
2025
Q1 		$7.01M Sell
811,805
-210,800
-21% -$1.5M 0.12% 153
2024
Q4 		$6.84M Buy
1,022,605
+536,196
+110% +$3.98M 0.11% 166
2024
Q3 		$3.5M Buy
486,409
+56,499
+13% +$520K 0.05% 227
2024
Q2 		$4.47M Sell
429,910
-38,315
-8% -$383K 0.07% 200
2024
Q1 		$4.71M Buy
+468,225
New +$5.03M 0.07% 204
2022
Q4 		– Sell
-353,285
Closed -$7.03M – 563
2022
Q3 		$7.03M Buy
353,285
+38,216
+12% +$946K 0.12% 166
2022
Q2 		$6.44M Sell
315,069
-47,718
-13% -$1.18M 0.1% 173
2022
Q1 		$11M Buy
+362,787
New +$14.2M 0.16% 139

Other funds holding HLF

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ROIC
Route One Investment Company San Francisco, California $2.49B AUM 10.92% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SP
Solel Partners Boston, Massachusetts $588M AUM 14.47% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Thompson Siegel & Walmsley's HLF Position: Q2 2026 in Review

Thompson Siegel & Walmsley increased its Herbalife (HLF) stake by 31% in Q2 2026, buying an estimated $1.16M and bringing the position to 359,816 shares worth $4.73M. The position accounts for 0.08% of the portfolio, ranked #237.

Thompson Siegel & Walmsley first reported a position in HLF in Q1 2022 and has held it in 13 quarters since. The position peaked at $11M in Q1 2022. 234 funds tracked by Wall St. Rank hold HLF as of Q2 2026.

  • Thompson Siegel & Walmsley held 359,816 shares of Herbalife worth $4.73M as of Q2 2026.
  • Thompson Siegel & Walmsley bought 84,124 Herbalife shares in Q2 2026, an estimated $1.16M.
  • Herbalife made up 0.08% of Thompson Siegel & Walmsley's portfolio in Q2 2026, its #237 holding.
  • Thompson Siegel & Walmsley first reported a position in Herbalife in Q1 2022 and has held it in 13 quarters since.
  • Thompson Siegel & Walmsley's Herbalife position peaked at $11M in Q1 2022.
  • 234 funds tracked by Wall St. Rank held Herbalife as of Q2 2026.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2026, filed 11 Aug 2026.